Physician profile
Sameer K Singh
NPI 1831357227
$1,821.19
in general payments reported to CMS, 2019-2025
21 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $205 · 2021: $294 · 2022: $32.00 · 2023: $33.55 · 2024: $264 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $381.97 | 2019-2024 | Myrbetriq, Xtandi |
| Abbott Laboratories | $190.35 | 2022-2024 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Biotech, INC. | $174.56 | 2019-2020 | |
| Edwards Lifesciences Corporation | $158.68 | 2019 | |
| Storz Medical America, INC. | $137.53 | 2025 | |
| Tolmar, INC. | $129.95 | 2023-2025 | Jatenzo, Eligard |
| Endo USA, INC. | $100.65 | 2024-2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $90.91 | 2021 | |
| Pfizer INC. | $88.46 | 2019-2021 | |
| Boston Scientific Corporation | $60.35 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $55.13 | 2019-2021 | |
| Coloplast Corp | $48.73 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.73 | 2020 | |
| Ferring Pharmaceuticals INC. | $41.31 | 2019 | |
| Travere Therapeutics, INC. | $29.17 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.51 | 2020 | |
| Metuchen Pharmaceuticals | $18.44 | 2019 | |
| Amgen INC. | $16.57 | 2019 | |
| Olympus America INC. | $15.45 | 2020 | |
| Dendreon Pharmaceuticals LLC | $13.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.